BioSpace News Archive

Basilea Pharmaceutica Ltd. announced that it has been awarded an additional USD 4.3 million of non-dilutive funding by the Biomedical Advanced Research and Development Agency, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, in the context of the existing contract to support the phase 3 program of Basilea’s antibiotic ceftobiprole.

Urethral bulking is used to treat urinary incontinence. It involves injecting material, such as collagen, around the urethra.

The demand within the global market for splenomegaly therapeutics has been rising on account of advancements in the field of spleen-care.

The increasing prevalence of cancer cases and the advent of the latest technology to combat various cancer types emerge as a prime factor augmenting the growth of the global radiotherapy market.

The two main types of materials of contact lenses are soft and hard or rigid. Scleral lens is a type of hard or rigid material contact lens, and it’s generally larger in diameter than other contact lenses.

Preeclampsia is a hypertensive disorder of pregnancy and affects about 5% of pregnant women globally, out of whom 0.5% to 1% develop it in the severe form.

Growing shortage of skilled healthcare professionals in all worldwide locations is stimulating prodigious demand for medical recruitment services.

The popularity of various formulations in the fixed dose combination drugs market stems largely from the fact that they hold great promise in improving adherence to long-term multi-drug therapies.

Targovax ASA, announces that members of its executive management team is invited to present and participate at upcoming conferences.

Oxurion NV, a biopharmaceutical company developing next generation standard of care therapies for retinal vascular disorders, announces the publication of two related papers in the Journal of Pharmacokinetics and Pharmacodynamics entitled “Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach.”